Mouse Anti-DDO Recombinant Antibody (3F7) (V2LY-0125-LY1324)

Katane, M., Kuwabara, H., Nakayama, K., Saitoh, Y., Miyamoto, T., Sekine, M., & Homma, H. (2020). Biochemical characterization of d-aspartate oxidase from Caenorhabditis elegans: Its potential use in the determination of free d-glutamate in biological samples. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics, 1868(8), 140442.

Takahashi, S. (2020). d-Aspartate oxidase: Distribution, functions, properties, and biotechnological applications. Applied microbiology and biotechnology, 104(7), 2883-2895.

De Rosa, A., Mastrostefano, F., Di Maio, A., Nuzzo, T., Saitoh, Y., Katane, M., ... & Errico, F. (2020). Prenatal expression of d-aspartate oxidase causes early cerebral d-aspartate depletion and influences brain morphology and cognitive functions at adulthood. Amino Acids, 52(4), 597-617.

Nuzzo, T., Feligioni, M., Cristino, L., Pagano, I., Marcelli, S., Iannuzzi, F., ... & Usiello, A. (2019). Free d-aspartate triggers NMDA receptor-dependent cell death in primary cortical neurons and perturbs JNK activation, Tau phosphorylation, and protein SUMOylation in the cerebral cortex of mice lacking d-aspartate oxidase activity. Experimental neurology, 317, 51-65.

Katane, M., Kuwabara, H., Nakayama, K., Saitoh, Y., Miyamoto, T., Sekine, M., & Homma, H. (2018). Rat d-aspartate oxidase is more similar to the human enzyme than the mouse enzyme. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics, 1866(7), 806-812.

Katane, M., Kanazawa, R., Kobayashi, R., Oishi, M., Nakayama, K., Saitoh, Y., ... & Homma, H. (2017). Structure–function relationships in human D-aspartate oxidase: characterisation of variants corresponding to known single nucleotide polymorphisms. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics, 1865(9), 1129-1140.

Sacchi, S., Novellis, V. D., Paolone, G., Nuzzo, T., Iannotta, M., Belardo, C., ... & Usiello, A. (2017). Olanzapine, but not clozapine, increases glutamate release in the prefrontal cortex of freely moving mice by inhibiting D-aspartate oxidase activity. Scientific reports, 7(1), 1-13.

Nuzzo, T., Sacchi, S., Errico, F., Keller, S., Palumbo, O., Florio, E., ... & Usiello, A. (2017). Decreased free d-aspartate levels are linked to enhanced d-aspartate oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patients. npj Schizophrenia, 3(1), 1-10.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols